| Psychometric Properties of a Structured Diagnostic Interview for DSM-5 Anxiety, Mood, and Obsessive-Compulsive and Related Disorders DF Tolin, C Gilliam, BM Wootton, W Bowe, LB Bragdon, E Davis, ... Assessment 25 (1), 3-13, 2018 | 249 | 2018 |
| The evidence-based pharmacotherapy of social anxiety disorder C Blanco, LB Bragdon, FR Schneier, MR Liebowitz International Journal of Neuropsychopharmacology 16 (1), 235-249, 2013 | 151 | 2013 |
| A contemporary psychometric evaluation of the Obsessive Compulsive Inventory—Revised (OCI-R). BM Wootton, GJ Diefenbach, LB Bragdon, G Steketee, RO Frost, DF Tolin Psychological assessment 27 (3), 874, 2015 | 92 | 2015 |
| Repetitive transcranial magnetic stimulation for generalised anxiety disorder: a pilot randomised, double-blind, sham-controlled trial GJ Diefenbach, LB Bragdon, L Zertuche, CJ Hyatt, LS Hallion, DF Tolin, ... The British Journal of Psychiatry 209 (3), 222-228, 2016 | 88 | 2016 |
| Does neuropsychological performance in OCD relate to different symptoms? A meta‐analysis comparing the symmetry and obsessing dimensions LB Bragdon, BE Gibb, ME Coles Depression and anxiety 35 (8), 761-774, 2018 | 63 | 2018 |
| Resting-state functional connectivity in generalized anxiety disorder and social anxiety disorder: evidence for a dimensional approach L Rabany, GJ Diefenbach, LB Bragdon, BP Pittman, L Zertuche, DF Tolin, ... Brain connectivity 7 (5), 289-298, 2017 | 58 | 2017 |
| Treating anxious depression using repetitive transcranial magnetic stimulation GJ Diefenbach, L Bragdon, JW Goethe Journal of affective disorders 151 (1), 365-368, 2013 | 55 | 2013 |
| Examining heterogeneity of obsessive-compulsive disorder: Evidence for subgroups based on motivations LB Bragdon, ME Coles Journal of Anxiety Disorders 45, 64-71, 2017 | 52 | 2017 |
| Psychometric properties of the Overall Anxiety Severity and Impairment Scale (OASIS) among psychiatric outpatients LB Bragdon, GJ Diefenbach, S Hannan, DF Tolin Journal of Affective Disorders 201, 112-115, 2016 | 36 | 2016 |
| Treatment outcome and predictors of internet guided self-help for obsessive-compulsive disorder GJ Diefenbach, BM Wootton, LB Bragdon, SJ Moshier, DF Tolin Behavior Therapy 46 (6), 764-774, 2015 | 33 | 2015 |
| Three-year outcomes of adults with anxiety and related disorders following cognitive-behavioral therapy in a non-research clinical setting BM Wootton, LB Bragdon, SA Steinman, DF Tolin Journal of anxiety disorders 31, 28-31, 2015 | 32 | 2015 |
| Geriatric anxiety inventory: factor structure and associations with cognitive status GJ Diefenbach, LB Bragdon, K Blank The American Journal of Geriatric Psychiatry 22 (12), 1418-1426, 2014 | 31 | 2014 |
| The relationship between self-reported and objective neuropsychological impairments in patients with hoarding disorder SJ Moshier, BM Wootton, LB Bragdon, DF Tolin, E Davis, J DiMauro, ... Journal of Obsessive-Compulsive and Related Disorders 9, 9-15, 2016 | 27 | 2016 |
| Neural functional architecture and modulation during decision making under uncertainty in individuals with generalized anxiety disorder M Assaf, L Rabany, L Zertuche, L Bragdon, D Tolin, J Goethe, ... Brain and Behavior 8 (8), e01015, 2018 | 24 | 2018 |
| Diagnostic interview for anxiety, mood, and OCD and related disorders (DIAMOND) DF Tolin, BM Wootton, W Bowe, LB Bragdon, EC Davis, CM Gilliam, ... Hartford, CT: Institute of Living/Hartford HealthCare Corporation, 2013 | 16 | 2013 |
| Psychopharmacology for social anxiety disorder C Blanco, L Bragdon, FR Schneier, MR Liebowitz Social anxiety, 625-659, 2014 | 11 | 2014 |
| Interoception and obsessive-compulsive disorder: a review of current evidence and future directions LB Bragdon, GK Eng, A Belanger, KA Collins, ER Stern Frontiers in Psychiatry 12, 686482, 2021 | 9 | 2021 |
| Conditioned physiological reactivity and PTSD symptoms across the menstrual cycle: Anxiety sensitivity as a moderator. JK Carpenter, L Bragdon, SL Pineles Psychological Trauma: Theory, Research, Practice, and Policy 14 (3), 453, 2022 | 6 | 2022 |
| Diagnostic Interview for anxiety, mood, and OCD and related neuropsychiatric disorders (DIAMOND) D Tolin, W Bowe, E Davis, S Hannan, K Springer, B Worden, SA Steinman Hartford, CT: The Institute of Living, Hartford Healthcare Corporation, 2016 | 5 | 2016 |
| Pharmacological treatment for social anxiety disorder FR Schneier, LB Bragdon, C Blanco, MR Liebowitz The wiley blackwell handbook of social anxiety disorder, 521-546, 2014 | 5 | 2014 |
David F. TolinInstitute of Living and Yale University School of MedicineVerified email at hhchealth.org
